Stockreport

BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates

BeOne Medicines Ltd. - American Depositary Shares  (ONC) 
PDF Third quarter total revenues increased 41% to $1.4 billion versus third quarter 2024Global BRUKINSA® (zanubrutinib) revenues increased 51% to $1.0 billion versus third q [Read more]